MaxQ AI, an Israeli-based medical diagnostic AI company has launched the company’s new ACCIPIO Ax solution, which features SliceMap, an integrated view that guides clinicians rapidly to CT slices with suspected intracranial hemorrhage (ICH) without leaving their PACS viewer. Slice-Level Intracranial Hemorrhage DetectionACCIPIO Ax is FDA Cleared, CE Approved, and the second component of MaxQ AI’s ACCIPIO ICH Platform, the complete ICH solution for stroke and head trauma assessment. Radiology
Read More
Intermountain and MDClone Integrate to Transform Patient Data into Actionable Insights
Intermountain Healthcare, today announced it is teaming up with Israeli healthcare IT company MDClone to increase caregivers’ ability to transform patient data into information they can use to help people lead the healthiest lives possible. As part of the collaboration, MDClone will share a new approach to healthcare data access, analytics, and research with Intermountain. The new partnership will further transform its existing rich data sources into more meaningful information that will enable
Read More
Israeli Telehealth Startup TytoCare Extends Series C, Bringing Total Funds to $33.5M
TytoCare, an Israeli-based telehealth company, today announced it has extended its Series C funding to add key strategic investors, bringing the total funds raised to $33.5M. This is an extension of the oversubscribed 2018 round led by Ping An Global Voyager Fund with new investors Shenzhen Capital Group of China, Japan’s Itochu, and Sanford Health of the US.Founded in 2012, TytoCare has three telehealth products: TytoHome™ for consumers, TytoPro™ for professionals, and TytoClinic™ for remote
Read More
aMoon II Raises $600M Digital Health Fund to Invest in Mid to Late-Stage Companies
Israeli-based health tech and life sciences venture fund aMoon II has raised $600 million from investors and aims to raise up to $750 million by its close in February, Reuters reported. The fund's objective is to generate strong investment returns by partnering with promising mid-late-stage companies in Israel and in select other global centers of healthtech innovation.aMoon II Investment FocusFounded in 2018, aMoon II secured a $250 million investment commitment from Credit Suisse’s asset
Read More
EarlySense Raises $39M to Expand Contact-Free Monitoring & Analytics Solution
Israeli digital health startup, EarlySense, a contact-free continuous monitoring solutions provider, announced today that it has raised $39 million in funding from Hill-Rom and Wells Fargo Strategic Capital. The round also included participation from BlueRed Capital, Israel Innovation Fund, Argos Capital and Hotung Capital. Existing investors, Pitango Venture Capital and JK&B Venture Capital. Founded in 2004, EarlySense’s FDA-cleared and CE-approved solutions are used by healthcare
Read More
Medtronic Acquires Nutrino Health to Integrate Diabetes Capabilities with Nutritional Data
Medtronic acquires Nutrino Health to augment diabetes capabilities with Nutrino’s nutritional database and data science. Medtronic, a provider of medical technology announced it will acquire Tel Aviv-based Nutrino Health, a provider of nutrition-related data services, analytics, and technologies. For Medtronic, the acquisition is an opportunity to improve clinical outcomes for people with diabetes through the integration of Nutrino’s extensive food analysis infrastructure, nutrition science
Read More
Israeli Startup Alpha Tau Medical Raises $29M for Radiation Cancer Therapy
Alpha Tau Medical, an Israeli medical tech startup developer of a breakthrough alpha radiation cancer therapy, today announced it has raised $29 million in funding led by Shavit Capital. The round also included participation from OurCrowd.com, Medison Ventures and significant private investors contributed to the funding round including the preeminent international social impact VC and private equity investors, Sir Ronald Cohen and Alan Patricof, the founders of Apax Partners.Founded in 2016,
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
Zebra Medical Vision Raises $30M, Unveils AI-Based Chest X-Ray Reader
Zebra Medical Vision, an Israeli-based machine and deep learning startup utilizing big data to diagnose diseases far better than radiology has raised $30 million in Series C funding led by aMoon Ventures. The round also included particpation from Aurum, Johnson & Johnson Innovation JJDC Inc. and Intermountain Healthcare and leading global AI scientists Professor Fei Fei Lee and Richard Socher. The latest round brings the total investment in the company to $50M. Founded in 2014, Zebra
Read More
Zebra Medical Vision Granted CE Approval for Breast Cancer Detection Algorithm
Zebra Medical Vision, a machine and deep learning startup utilizing big data to diagnose diseases far better than radiology has received CE approval for its 7th disease detecting algorithm that will detect one of the deadliest of all: breast cancer. The algorithm is capable of detecting suspected malignant lesions in mammography scans. It is the latest addition to other automated tools announced in the past as part of it’s “All-In-One” AI1 business model, among them algorithms that automatically
Read More